Re:Three New Longevity Startups
by DrAwdeOccarim on Saturday January 11, 2020 @05:37PM
(#22022869)
Cool, thanks for the reply. Are the approved use parenteral? Have you considered aptamers?
[ Parent
| on HN ]
Re:Three New Longevity Startups
by BiochemOki on Saturday January 11, 2020 @06:23PM
(#22023150)
Yes, we are looking at IV, as others have done already clinically. We aren't looking at aptamers or other clever ways of binding small toxic biomolecules. I hope that other groups are!
Re:Three New Longevity Startups
by DrAwdeOccarim on Sunday January 12, 2020 @11:14AM
(#22026984)
This is a pretty interesting paper: https://stm.sciencemag.org/content/8/333/333ra50
Is there a chance that you are developing CD that target 7KC but at the end of the day, it dissolved chol-containing plaques inherently and that's where you'll derive the benefit from?